Structural characteristics of immunogenic liver-stage antigens derived from P. falciparum malarial proteins

Biochemical and Biophysical Research Communications

Volumn 384, Issue 4, 2009, Pages 455-460

  Cifuentes, Gladys ^a,b   Vanegas, Magnolia ^a,b   Martinez, Nora Lorena ^a,b   Pirajan, Camilo ^a,b   Patarroyo, Manuel Elkin ^a,c  

^a FUNDACIÓN INSTITUTO DE INMUNOLOGÍA DE COLOMBIA FIDIC   (Colombia)

^b UNIVERSIDAD DEL ROSARIO   (Colombia)

^c UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

Author keywords

HLA DR 1* molecules; LSA 1; Malaria; MHCII peptide TCR complex; SALSA

Indexed keywords

HLA DR ANTIGEN; LIVER STAGE ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MALARIA VACCINE; PARASITE ANTIGEN; PLASMODIUM FALCIPARUM MALARIAL PROTEIN; PROTOZOAL PROTEIN; SPOROZOITE AND LIVER STAGE ANTIGEN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN STRUCTURE; ARTICLE; CELL INVASION; CONTROLLED STUDY; HOST PARASITE INTERACTION; IMMUNE RESPONSE; IMMUNOGENICITY; LIVER CELL; MALARIA; MONKEY; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SPOROZOITE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, PROTOZOAN; HLA-DR ANTIGENS; IMMUNIZATION; LIVER; MALARIA VACCINES; MOLECULAR SEQUENCE DATA; PLASMODIUM FALCIPARUM; PROTEIN STRUCTURE, SECONDARY; PROTOZOAN PROTEINS; VACCINES, SUBUNIT;

PLASMODIUM FALCIPARUM;

EID: 65649150730     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.04.138     Document Type: Article

References (25)

1. Snow R.W., Guerra C.A., Noor A.M., et al. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434 (2005) 214-217
2. Clyde D.F., McCarthy V.C., Miller R.M., and Hornick R.B. Specificity of protection of man immunized against sporozoite-induced falciparum malaria. Am. J. Med. Sci. 266 (1973) 398-403
3. Fidock D.A., Gras-Masse H., Lepers J.P., et al. Plasmodium falciparum liver stage antigen-1 is well conserved and contains potent B and T-cell determinants. J. Immunol. 153 (1994) 190-204
4. Zhu J., and Hollingdale M.R. Structure of Plasmodium falciparum liver stage antigen 1. Mol. Biochem. Parasitol. 48 (1991) 223-226
5. Kurtis J.D., Hollingdale M.R., Luty A.J., et al. Pre-erythrocytic immunity to Plasmodium falciparum: the case for an LSA-1 vaccine. Trends Parasitol. 17 (2001) 219-223
6. Garcia J.E., Puentes A., López R., et al. Peptides of the liver stage antigen-1 (LSA-1) of Plasmodium falciparum bind to human hepatocytes. Peptides 24 (2003) 647-657
7. Bottius E., BenMohamed L., Brahimi K., et al. A novel Plasmodium falciparum sporozoite and liver stage antigen (SALSA) defines major B, T helper, and CTL epitopes. J. Immunol. 156 (1996) 2874-2884
8. Puentes A., García J., Vera R., et al. Sporozoite and liver stage antigen Plasmodium falciparum peptides bind specifically to human hepatocytes. Vaccine 22 (2004) 1150-1156
9. Garcia J.E., Puentes A., and Patarroyo M.E. Developmental Biology of Sporozoite-Host Interactions in Plasmodium falciparum Malaria: Implications for Vaccine Design. Clin. Microbiol. Rev. 19 (2006) 686-707
10. Houghten R.A. General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proc. Natl. Acad. Sci. USA 82 (1985) 5131-5135
11. Chen Y.H., Yang J.T., and Martinez H.M. Determination of the secondary structures of proteins by circular dichroism, optical rotatory dispersion. Biochemistry 11 (1972) 4120-4131
12. Rodríguez R., Moreno A., and Guzmán F. Studies in owl monkeys leading to the development of a synthetic vaccine against the asexual blood stages of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 43 (1990) 339-354
13. Buck M. Trifluoroethanol, colleagues: cosolvents come of age. Recent studies with peptides and proteins. Q Rev. Biophys. 31 (1998) 297-355
14. 1H NMR spectra of proteins via double quantum filtering. Biochem. Biophys. Res. Commun. 117 (1983) 479-485
15. Bax A., and Davis D.G. MLEV-17 based two dimensional homonuclear magnetization transfer spectroscopy. J. Magn. Reson. 65 (1985) 355-360
16. Jeener J., Meier B.H., Backman P., and Ernst R.R. Investigation of enhance processes by two dimensional NMR spectroscopy. J. Chem. Phys. 71 (1979) 4546-4553
17. Vargas L.E., Parra C.A., Salazar L.M., et al. MHC allele-specific binding of a malaria peptide makes it become promiscuous on fitting a glycine residue into pocket 6. Biochem. Biophys. Res. Commun. 307 (2003) 148-156
18. Patarroyo M.E., Alba M.P., Vargas L.E., et al. Peptides inducing short-lived antibody responses against Plasmodium falciparum malaria have shorter structures and are read in a different MHC II functional register. Biochemistry 44 (2005) 6745-6754
19. Kabsch W., and Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22 (1983) 2577-2637
20. Reyes C., Patarroyo M.E., Vargas L.E., et al. Functional, structural, and immunological compartmentalisation of malaria invasive proteins. Biochem. Biophys. Res. Commun. 354 (2007) 363-371
21. Krzych U., Lyon J.A., Jareed T., et al. T lymphocytes from volunteers immunized with irradiated Plasmodium falciparum sporozoites recognize liver and blood stage malaria antigens. J. Immunol. 155 (1995) 4072-4077
22. Doolan D.L., and Hoffman S.L. The complexity of protective immunity against liver-stage malaria. J. Immunol. 165 (2000) 1453-1462
23. Migot-Nabias F., Luty A.J., Minh T.N., et al. HLA alleles in relation to specific immunity to liver stage antigen-1 from plasmodium falciparum in Gabon. Genes Immun. 2 (2001) 4-10
24. *10501-restricted Th1 type immune responses to Plasmodium falciparum liver stage antigen 1 protect against malaria anemia and reinfections. J. Infect. Dis. 183 (2001) 168-172
25. BenMohamed L., Thomas A., and Druilhe P. Long-term multiepitopic cytotoxic-T-lymphocyte responses induced in chimpanzees by combinations of Plasmodium falciparum liver-stage peptides and lipopeptides. Infect. Immun. 72 (2004) 4376-4384